Vibrio is a genus of anaerobic, non-spore forming, gram-negative bacteria that are curved rod shape. All the species of the vibrio genus are motile pathogens and have flagella with sheaths. Several species of these bacteria are capable of causing various conditions such as cholera, gastroenteritis, primary septicemia, cell necrosis and otitis.
Read Report Overview - https://www.transparencymarketresearch.com/vibrio-diagnostics-market.html
The following are some of the diagnostic techniques used for the detection of various diseases associated with vibrio:
- Enzyme Immunoassays (EIA)
- PCR
- Flow Cytometry
- Monoclonal Antibodies
- Diagnostic Imaging
- Immuno-PCR
- Fluorescent Immunoassays
- Immunoprecipitation
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2271
Some of the end-users of vibrio diagnostics techniques are as follows:
- Public Health Laboratories
- Hospitals
- Private and commercial diagnostic labs
Geographically, Asia-Pacific is expected to lead the market due to factors such as poor sanitation, unsafe drinking water and unhygienic living conditions. According to the Centers for Disease Control and Prevention (CDC) disease such as Cholera, caused by Vibrio cholera, is rare in the U.S. and other developed nations.
Request for Analysis of COVID-19 Impact on Vibrio Diagnostics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2271
However, the disease is predominantly present in tropical regions including Southeast Asia, Africa and Middle East countries. According to an another report by the CDC, in 2011, globally almost 58 countries registered 589,854 cases of cholera and approximately 7,816 deaths from cholera to WHO in the same year.
The market for vibrio diagnostics market is primarily driven by the initiation of rapid diagnostics tests, rising awareness and increased healthcare expenditure. The market is also expected to witness growth due to other factors such as quick outcome, affordability of the diagnostics kits and devices. Furthermore, development of advance diagnostics techniques such as Polymearse Chain Reaction (PCR) and Enzyme Immunoassays (EIA) are also expected to the drive the market.
Pre Book Vibrio Diagnostics Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=2271<ype=S
Some of the major players in this industry segment include Abbott Laboratories, Becton, Dickinson and Company, DiamedixImpex S.A., Eiken Chemical Co. Ltd., Fujirebio Diagnostics Inc., Hologic Inc., Kreatech Holding BV, Lonza Group, Novartis Diagnostics and F. Hoffmann-La Roche Ltd.
More Trending Reports by Transparency Market Research –
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: https://www.biospace.com/article/chronic-obstructive-pulmonary-disease-copd-treatment-market-innovations-in-combination-therapy-to-dominate-market/
Fetal Monitoring Systems Market: https://www.prnewswire.com/news-releases/innovation-in-wearable-devices-driving-fetal-monitoring-systems-market-to-upward-growth-trajectory-tmr-301015185.html
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
